Observed Carfentanil Concentrations in 355 Blood Specimens from Forensic Investigations
The DOI matches its Crossref record.
Abstract
Carfentanil, a synthetic opioid with a potency estimated to be 10,000 times that of morphine (1, 2) and used to tranquilize large animals, has been analytically confirmed in over 350 whole-blood samples from forensic investigations submitted to our laboratory between October 2016 and April 2017. Most of these cases were acute drug deaths with histories of heroin abuse where carfentanil was substituted or added to the suspected heroin obtained by the decedent. Carfentanil poses a significant human health threat due to its potency, and since it is present at low concentrations in biological specimens, its detection is a challenge to the analytical capabilities of some laboratories. In October 2016, our laboratory launched a quantitative liquid chromatography tandem mass spectrometry (LC–MS-MS) assay for carfentanil. Sample preparation included protein precipitation of blood followed by solid phase extraction. The method was linear over the calibration range of 0.10–10 ng/mL with a limit of detection of 0.03 ng/mL. Carfentanil was confirmed in 355 cases where, in most cases, it was initially identified by a Liquid Chromatography Time of Flight Mass Spectrometry (LC–TOF/MS) screen. The mean (±SD) and median concentrations (excluding cases <0.10 ng/mL) were 0.57 (±0.97) and 0.38 ng/mL, respectively, (range: 0.10–14 ng/mL). Figure 1 shows the distribution of concentrations seen in all positive samples (post mortem and human performance). Of the 289 cases where age was provided, the mean (±SD) and median age was 40 (±12.5) and 39 years, respectively, and ranged from 20 to 72. Approximately 54% of the subjects were between the ages of 25 and 40; 75% of the subjects were male. Of the reported cases, 223 were from Michigan, 39 from Florida, 35 from Ohio, with the remainder from various states mainly east of the Mississippi river. Histogram depicting frequency of positive carfentanil test results. There were four human performance-related cases—all from Pennsylvania—which was surprising considering the potency of the drug. Analytical findings in these cases are reported in Table I. Case 1 was a female found unresponsive by Emergency Medical Services (EMS) in her vehicle, which was located in the middle of a highway; EMS administered 2 mg of naloxone and the individual responded immediately. She was an IV heroin user and a used syringe was found on scene. Case 2 was also a female who was located by police after 911 calls reporting erratic driving. Police found her car parked in a driveway shortly after the calls were made, conscious, but clearly under the influence of central nervous system depressants, and more specifically, narcotics. The history on the remaining two cases is not known. In addition to carfentanil, fentanyl or its analog furanyl fentanyl were detected in all cases. Toxicology results (blood) from carfentanil-related human performance investigations Toxicology results (blood) from carfentanil-related human performance investigations It is apparent that carfentanil is commonly detected with other illicit substances, notably heroin, fentanyl, and cocaine. Although not all 355 cases were tested for other drugs, when they were ~48% of positive carfentanil cases included one other opioid of which the majority were morphine and/or fentanyl; 6-acetylmorphine was confirmed in 10% of these cases. Cocaine and its metabolites was another common finding (32%). It cannot be determined solely from toxicology results if the other drugs detected were due to multiple drug administrations or were a result of a substituted or contaminated product. However, carfentanil-laced heroin has been reported in drug seizures (3), so it is likely that the combinations are reflective of these substances being used by recreational drug abusers. There is a real concern that with the carfentanil export ban announced by China in February 2017 (4), drug manufacturers will turn to even more potent opioids, posing a continued public health threat and even greater analytical challenges for laboratories. The authors are grateful to the Drug Enforcement Administration (DEA) for providing specified case details.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Isotonitazene Quantitation and Metabolite Discovery in Authentic Forensic Casework
Krotulski, A. J., Papsun, D. M., Kacinko, S. L., & Logan, B. K. (2020) · Journal of Analytical Toxicology · doi:10.1093/jat/bkaa016 · Cited by 146
Self-citationKrotulski, A. J., Papsun, D. M., Noble, C., Kacinko, S. L., & Logan, B. K. (2021) · Journal of Forensic Sciences · doi:10.1111/1556-4029.14623 · Cited by 47
Self-citationBhuiyan, I., Tobias, S., & Ti, L. (2023) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2023.2226312 · Cited by 27
Metadata
- Authors
- Papsun, D., Isenschmid, D., & Logan, B. K.
- Venue
- Journal of Analytical Toxicology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-08-31
- Volume
- 41
- Issue
- 9
- Pages
- 777-778
- ISSN
- 0146-4760 (ISSN-L)
- 1945-2403
- OpenAlex
- W2750795658
- Cited by
- 37
- References
- 0
- FWCI
- 9.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Observed Carfentanil Concentrations in 355 Blood Specimens from Forensic Investigations. https://app.cochat.ai/papers/10.1093/jat/bkx068
- The paper
- Papsun, D., Isenschmid, D., & Logan, B. K. (2017). Observed Carfentanil Concentrations in 355 Blood Specimens from Forensic Investigations. Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bkx068
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.